These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 804956)

  • 1. A mouse intracerebral infection with Neisseria gonorrhoeae.
    Diena BB; Ryan A; Ashton FE; Wallace R; Perry MB; Daoust V
    Br J Vener Dis; 1975 Feb; 51(1):22-4. PubMed ID: 804956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Female Mouse Model of Neisseria gonorrhoeae Infection.
    Raterman EL; Jerse AE
    Methods Mol Biol; 2019; 1997():413-429. PubMed ID: 31119637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lipopolysaccharide (R type) as a common antigen of Neisseria gonorrhoeae. I. Immunizing properties.
    Diena BB; Ashton FE; Ryan A; Wallace R
    Can J Microbiol; 1978 Feb; 24(2):117-23. PubMed ID: 417780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.
    Edwards JL; Jennings MP; Apicella MA; Seib KL
    Crit Rev Microbiol; 2016 Nov; 42(6):928-41. PubMed ID: 26805040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress Toward a Gonococcal Vaccine: The Way Forward.
    Russell MW; Jerse AE; Gray-Owen SD
    Front Immunol; 2019; 10():2417. PubMed ID: 31681305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental Human Infection with Neisseria gonorrhoeae.
    Hobbs MM; Duncan JA
    Methods Mol Biol; 2019; 1997():431-452. PubMed ID: 31119638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of chicks to experimental infections with Neisseria gonorrhoeae.
    Shaffer MF; Peirce WA; Lislie GA
    J Infect Dis; 1975 Mar; 131(3):277-80. PubMed ID: 805183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biology of the Gonococcus: Disease and Pathogenesis.
    Shaughnessy J; Ram S; Rice PA
    Methods Mol Biol; 2019; 1997():1-27. PubMed ID: 31119614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could vaccination against Neisseria gonorrhoeae be on the horizon?
    Russell MW
    Future Microbiol; 2018 Apr; 13():495-497. PubMed ID: 29517283
    [No Abstract]   [Full Text] [Related]  

  • 10. Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development.
    Cohen MS; Cannon JG; Jerse AE; Charniga LM; Isbey SF; Whicker LG
    J Infect Dis; 1994 Mar; 169(3):532-7. PubMed ID: 8158024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neisseria gonorrhoeae catalase is not required for experimental genital tract infection despite the induction of a localized neutrophil response.
    Soler-García AA; Jerse AE
    Infect Immun; 2007 May; 75(5):2225-33. PubMed ID: 17296753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17beta-estradiol-treated mice.
    Song W; Condron S; Mocca BT; Veit SJ; Hill D; Abbas A; Jerse AE
    Vaccine; 2008 Oct; 26(45):5741-51. PubMed ID: 18762223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental gonococcal urethritis and reinfection with homologous gonococci in male volunteers.
    Schmidt KA; Schneider H; Lindstrom JA; Boslego JW; Warren RA; Van de Verg L; Deal CD; McClain JB; Griffiss JM
    Sex Transm Dis; 2001 Oct; 28(10):555-64. PubMed ID: 11689753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of Neisseria gonorrhoeae genital tract infection with patented technology of physical antimicrobial dermal film in a murine model].
    Fang XL; Dai YT; Yin YP; Lan HJ; Zhou LH
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):405-8. PubMed ID: 21418914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common heat stable protective antigen in gonococci.
    Ito JI; Corbeil LB; Wunderlich AC; McCutchan JA; Braude AI
    Trans Assoc Am Physicians; 1979; 92():160-8. PubMed ID: 95067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody to reduction modifiable protein increases the bacterial burden and the duration of gonococcal infection in a mouse model.
    Gulati S; Mu X; Zheng B; Reed GW; Ram S; Rice PA
    J Infect Dis; 2015 Jul; 212(2):311-5. PubMed ID: 25596304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human experimentation with Neisseria gonorrhoeae: progress and goals.
    Cohen MS; Cannon JG
    J Infect Dis; 1999 Mar; 179 Suppl 2():S375-9. PubMed ID: 10081510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of two novel Neisseria gonorrhoeae virulent components: the macrophage infectivity potentiator and the outer membrane protein A.
    Starnino S; Leuzzi R; Ghisetti V; De Francesco MA; Cusini M; Impara G; Galluppi E; Pizza M; Stefanelli P
    New Microbiol; 2010 Apr; 33(2):167-70. PubMed ID: 20518279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of antigenic variation in Neisseria gonorrhoeae.
    Seifert HS
    Mol Cell Biol Hum Dis Ser; 1992; 1():1-22. PubMed ID: 1341640
    [No Abstract]   [Full Text] [Related]  

  • 20. Neisseria gonorrhoeae: experimental infection of laboratory animals.
    Arko RJ
    Science; 1972 Sep; 177(4055):1200-1. PubMed ID: 4626945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.